BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 25881039)

  • 1. Interleukin-6 and pro inflammatory status in the breast tumor microenvironment.
    Sanguinetti A; Santini D; Bonafè M; Taffurelli M; Avenia N
    World J Surg Oncol; 2015 Mar; 13():129. PubMed ID: 25881039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland.
    Sansone P; Storci G; Tavolari S; Guarnieri T; Giovannini C; Taffurelli M; Ceccarelli C; Santini D; Paterini P; Marcu KB; Chieco P; Bonafè M
    J Clin Invest; 2007 Dec; 117(12):3988-4002. PubMed ID: 18060036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The basal-like breast carcinoma phenotype is regulated by SLUG gene expression.
    Storci G; Sansone P; Trere D; Tavolari S; Taffurelli M; Ceccarelli C; Guarnieri T; Paterini P; Pariali M; Montanaro L; Santini D; Chieco P; Bonafé M
    J Pathol; 2008 Jan; 214(1):25-37. PubMed ID: 17973239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of stem cell protein Piwil2 and piR-932 in breast cancer.
    Zhang H; Ren Y; Xu H; Pang D; Duan C; Liu C
    Surg Oncol; 2013 Dec; 22(4):217-23. PubMed ID: 23992744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Function of Integrin-Linked Kinase in Modulating the Stemness of IL-6-Abundant Breast Cancer Cells by Regulating γ-Secretase-Mediated Notch1 Activation in Caveolae.
    Hsu EC; Kulp SK; Huang HL; Tu HJ; Salunke SB; Sullivan NJ; Sun D; Wicha MS; Shapiro CL; Chen CS
    Neoplasia; 2015 Jun; 17(6):497-508. PubMed ID: 26152358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of beclin-1 in the microenvironment of invasive ductal carcinoma of the breast: correlation with prognosis and the cancer-stromal interaction.
    Morikawa A; Takeuchi T; Kito Y; Saigo C; Sakuratani T; Futamura M; Yoshida K
    PLoS One; 2015; 10(5):e0125762. PubMed ID: 25955408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between FGFR2 and RSK2-implications for breast cancer prognosis.
    Czaplinska D; Mieczkowski K; Supernat A; Skladanowski AC; Kordek R; Biernat W; Zaczek AJ; Romanska HM; Sadej R
    Tumour Biol; 2016 Oct; 37(10):13721-13731. PubMed ID: 27476168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid-Derived Suppressor Cells Endow Stem-like Qualities to Breast Cancer Cells through IL6/STAT3 and NO/NOTCH Cross-talk Signaling.
    Peng D; Tanikawa T; Li W; Zhao L; Vatan L; Szeliga W; Wan S; Wei S; Wang Y; Liu Y; Staroslawska E; Szubstarski F; Rolinski J; Grywalska E; Stanisławek A; Polkowski W; Kurylcio A; Kleer C; Chang AE; Wicha M; Sabel M; Zou W; Kryczek I
    Cancer Res; 2016 Jun; 76(11):3156-65. PubMed ID: 27197152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative determination, by real-time reverse transcription polymerase chain reaction, of aromatase mRNA in invasive ductal carcinoma of the breast.
    Zhang Z; Yamashita H; Toyama T; Omoto Y; Sugiura H; Hara Y; Wu X; Kobayashi S; Iwase H
    Breast Cancer Res; 2003; 5(6):R250-6. PubMed ID: 14580261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer associated fibroblasts express pro-inflammatory factors in human breast and ovarian tumors.
    Erez N; Glanz S; Raz Y; Avivi C; Barshack I
    Biochem Biophys Res Commun; 2013 Aug; 437(3):397-402. PubMed ID: 23831470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel biomarkers associated with poor patient outcomes in invasive breast carcinoma.
    Canevari RA; Marchi FA; Domingues MA; de Andrade VP; Caldeira JR; Verjovski-Almeida S; Rogatto SR; Reis EM
    Tumour Biol; 2016 Oct; 37(10):13855-13870. PubMed ID: 27485113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of the zinc-finger homeobox protein TSHZ2 releases GLI1 from the nuclear repressor complex to restore its transcriptional activity during mammary tumorigenesis.
    Riku M; Inaguma S; Ito H; Tsunoda T; Ikeda H; Kasai K
    Oncotarget; 2016 Feb; 7(5):5690-701. PubMed ID: 26744317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies.
    Jardé T; Caldefie-Chézet F; Goncalves-Mendes N; Mishellany F; Buechler C; Penault-Llorca F; Vasson MP
    Endocr Relat Cancer; 2009 Dec; 16(4):1197-210. PubMed ID: 19661131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
    Hildenbrand R; Schaaf A
    Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-6 involvement in epithelial cancers.
    Schafer ZT; Brugge JS
    J Clin Invest; 2007 Dec; 117(12):3660-3. PubMed ID: 18060028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p66Shc/Notch-3 interplay controls self-renewal and hypoxia survival in human stem/progenitor cells of the mammary gland expanded in vitro as mammospheres.
    Sansone P; Storci G; Giovannini C; Pandolfi S; Pianetti S; Taffurelli M; Santini D; Ceccarelli C; Chieco P; Bonafé M
    Stem Cells; 2007 Mar; 25(3):807-15. PubMed ID: 17158237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptor alpha gene expression in breast cancer tissues from the Iranian population--a pilot study.
    Hosseini A; Gopalan V; Nassiri M; Ghaffarzadehgan K; Aslaminejad A; Ghovvati S; Smith RA; Lam AK
    Asian Pac J Cancer Prev; 2014; 15(20):8789-91. PubMed ID: 25374208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level.
    Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H
    Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen-responsive finger protein as a new potential biomarker for breast cancer.
    Suzuki T; Urano T; Tsukui T; Horie-Inoue K; Moriya T; Ishida T; Muramatsu M; Ouchi Y; Sasano H; Inoue S
    Clin Cancer Res; 2005 Sep; 11(17):6148-54. PubMed ID: 16144914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulated IL-19 in breast cancer promotes tumor progression and affects clinical outcome.
    Hsing CH; Cheng HC; Hsu YH; Chan CH; Yeh CH; Li CF; Chang MS
    Clin Cancer Res; 2012 Feb; 18(3):713-25. PubMed ID: 22186257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.